AstraZeneca Clinical Research Collaboration Could Bring AED 180 Million to Abu Dhabi

On 21 October 2026, Abu Dhabi’s Department of Health, Cleveland Clinic Abu Dhabi and AstraZeneca announced a collaboration to explore up to 30 clinical trials by 2030. The initiative could deliver an estimated AED 180 million in life-sciences research investment, with the first six trials expected to begin by the end of 2026; contact HPC for a quotation on research computing, secure data processing and healthcare analytics.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.